ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, F. D.
Eur Respir J 2007; 29:179-184
Copyright ©ERS Journals Ltd 2007

Genes, environments, development and asthma: a reappraisal

F. D. Martinez

CORRESPONDENCE: F. D. Martinez, Arizona Respiratory Center, University of Arizona, 1501 N. Campbell Avenue, Tucson, AZ, USA. Fax: 1 5206266623. E-mail: fernando{at}arc.arizona.edu

Keywords: Asthma, development, environment, gene

Received: July 3, 2006
Accepted October 27, 2006

Significant advances have been made in our understanding of the role of genetic variation in determining complex human phenotypes such as asthma. It is now well established that there is no single "gene for asthma", in the way that the cystic fibrosis transmembrane receptor is the "gene for cystic fibrosis". It is also clear that among all genetic variants eventually found to be associated with asthma, only a few will be replicated, and in the same direction, in the majority of well-performed studies. Current evidence suggests that most asthma-related polymorphisms determine risk for the disease in a context-dependent manner, i.e. they interact with environmental factors, with polymorphisms in other genes and with the specific developmental phase of the disease in which the association is tested. Elucidating these complex interactions will allow us to understand better the heterogeneity of the disease and thus to develop therapeutic tools tailored to the specific form of the disease in each patient.




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
M. Castro, M. I. Ramirez, J. E. Gern, G. Cutting, G. Redding, J. S. Hagood, J. Whitsett, S. Abman, J. U. Raj, R. Barst, et al.
Strategic Plan for Pediatric Respiratory Diseases Research: An NHLBI Working Group Report
Proceedings of the ATS, January 15, 2009; 6(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. L. P. Brand, E. Baraldi, H. Bisgaard, A. L. Boner, J. A. Castro-Rodriguez, A. Custovic, J. de Blic, J. C. de Jongste, E. Eber, M. L. Everard, et al.
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
Eur. Respir. J., October 1, 2008; 32(4): 1096 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Orsmark-Pietras, E. Melen, J. Vendelin, S. Bruce, A. Laitinen, L. A. Laitinen, R. Lauener, J. Riedler, E. von Mutius, G. Doekes, et al.
Biological and genetic interaction between Tenascin C and Neuropeptide S receptor 1 in allergic diseases
Hum. Mol. Genet., June 1, 2008; 17(11): 1673 - 1682.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Sharma, J. Batra, U. Mabalirajan, S. Sharma, R. Nagarkatti, J. Aich, S. K. Sharma, P. V. Niphadkar, and B. Ghosh
A Genetic Variation in Inositol Polyphosphate 4 Phosphatase A Enhances Susceptibility to Asthma
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 712 - 719.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Kauffmann and R. Nadif
Candidate interactions
Eur. Respir. J., July 1, 2007; 30(1): 3 - 4.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.